PolyPid to Report Second Quarter 2021 Financial Results and Operational Highlights on August 11, 2021

Clean room
July 2021

PETAH TIKVA, Israel, July 28, 2021 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics, today announced that it will report its second quarter 2021 financial

Contact Us

    Your information will be processed in accordance with the Privacy Policy.

    Contact icon